Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock Including Additional Paid In Capital [Member]	Common Stock Including Additional Paid In Capital [Member] Class A Shares [Member]	Common Stock Including Additional Paid In Capital [Member] Class B Shares [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income [Member]	Prior Effect Of Business Combination Transaction [Member]	Prior Effect Of Business Combination Transaction [Member] Redeemable Series A Convertible Preferred Stock [Member]	Prior Effect Of Business Combination Transaction [Member] Common Stock Including Additional Paid In Capital [Member]	Prior Effect Of Business Combination Transaction [Member] Common Stock Including Additional Paid In Capital [Member] Class A Shares [Member]	Prior Effect Of Business Combination Transaction [Member] Common Stock Including Additional Paid In Capital [Member] Class B Shares [Member]	Prior Effect Of Business Combination Transaction [Member] Accumulated Deficit [Member]	Prior Effect Of Business Combination Transaction [Member] Accumulated Other Comprehensive Income [Member]
Balance at Dec. 31, 2020	$ 215,084	$ 289,482			$ (75,955)	$ 1,557	$ (52,437)	$ 267,521	$ 21,961			$ (75,955)	$ 1,557
Balance (in Shares) at Dec. 31, 2020			91,397,142	57,645,013				347,423,117		118,869,102	294,094,678
Retroactive Application Of Recapitalization Of Preferred Stock Due To Business Combination Transaction Shares								(347,423,117)		68,097,805
Retroactive Application Of Recapitalization Of Preferred Stock Due To Business Combination Transaction Value							267,521	$ (267,521)	267,521
Retroactive Application Of Recapitalization Of Common Stock Due To Business Combination Transaction Shares										95,569,765	236,449,665
Issuance and exchange of common stock, net of issuance costs upon the Merger	606,885	606,885
Issuance and exchange of common stock, net of issuance costs upon the Merger, shares			125,252,913	(56,645,013)
Issuance of common stock for in-process research and development expense	3,787	3,787
Issuance of common stock, shares			368,408
Treasury stock, acquired and retired, at cost			(368,408)
Stock-based compensation	1,566	1,566
Net loss	(20,402)				(20,402)
Other comprehensive income (loss)	(576)					(576)
Balance at Mar. 31, 2021	806,344	901,720			(96,357)	981
Balance (in Shares) at Mar. 31, 2021			216,650,055	1,000,000
Balance at Dec. 31, 2020	215,084	289,482			(75,955)	1,557	$ (52,437)	$ 267,521	$ 21,961			$ (75,955)	$ 1,557
Balance (in Shares) at Dec. 31, 2020			91,397,142	57,645,013				347,423,117		118,869,102	294,094,678
Issuance of common stock for in-process research and development expense	3,787
Net loss	(39,735)
Balance at Jun. 30, 2021	788,935	903,868			(115,690)	757
Balance (in Shares) at Jun. 30, 2021			216,759,082	1,000,000
Balance at Mar. 31, 2021	806,344	901,720			(96,357)	981
Balance (in Shares) at Mar. 31, 2021			216,650,055	1,000,000
Issuance and exchange of common stock, net of issuance costs upon the Merger	(195)	(195)
Exercise of stock options, shares			109,027
Exercise of stock options	190	190
Stock-based compensation	2,153	2,153
Net loss	(19,333)				(19,333)
Other comprehensive income (loss)	(224)					(224)
Balance at Jun. 30, 2021	788,935	903,868			(115,690)	757
Balance (in Shares) at Jun. 30, 2021			216,759,082	1,000,000
Balance at Dec. 31, 2021	745,997	909,985			(162,803)	(1,185)
Balance (in Shares) at Dec. 31, 2021			216,948,568	1,000,000
Exercise of stock options, shares			180,557
Exercise of stock options	314	314
Stock-based compensation	3,577	3,577
Net loss	(21,293)				(21,293)
Other comprehensive income (loss)	(5,032)					(5,032)
Balance at Mar. 31, 2022	723,563	913,876			(184,096)	(6,217)
Balance (in Shares) at Mar. 31, 2022			217,129,125	1,000,000
Balance at Dec. 31, 2021	745,997	909,985			(162,803)	(1,185)
Balance (in Shares) at Dec. 31, 2021			216,948,568	1,000,000
Issuance of common stock for in-process research and development expense
Net loss	(56,151)
Balance at Jun. 30, 2022	693,079	919,011			(218,954)	(6,978)
Balance (in Shares) at Jun. 30, 2022			217,244,300	1,000,000
Balance at Mar. 31, 2022	723,563	913,876			(184,096)	(6,217)
Balance (in Shares) at Mar. 31, 2022			217,129,125	1,000,000
Exercise of stock options, shares			31,896
Exercise of stock options	56	56
Exercise of warrants			$ 10
Issuance of common stock for purchase under ESPP, shares			83,269
Issuance of common stock for purchase under the ESPP	292	292
Stock-based compensation	4,787	4,787
Net loss	(34,858)				(34,858)
Other comprehensive income (loss)	(761)					(761)
Balance at Jun. 30, 2022	$ 693,079	$ 919,011			$ (218,954)	$ (6,978)
Balance (in Shares) at Jun. 30, 2022			217,244,300	1,000,000